Literature DB >> 3091505

T-cell-independent macrophage activation in mice induced with rRNA from Listeria monocytogenes and dimethyldioctadecylammonium bromide.

J F van den Bosch, I Y Kanis, A C Antonissen, W A Buurman, C P van Boven.   

Abstract

Purified rRNA from Listeria monocytogenes or Pseudomonas aeruginosa injected in combination with dimethyldioctadecylammonium bromide (DDA), protects mice nonspecifically against a lethal challenge of various extra- and intracellular bacteria. In the present study vaccination of BALB/c as well as C57BL/Ka mice with listerial RNA-DDA resulted in activation of fixed-tissue macrophages, as measured by an enhanced in vivo L. monocytogenes killing in spleen and liver. Evidence was found that macrophage activation by vaccination with rRNA-DDA occurred by a T-cell-independent mechanism. Treatment of mice with cyclosporin A had no effect on the enhanced L. monocytogenes killing induced with RNA-DDA; in vitro exposure of RNA-DDA to spleen cell cultures did not give rise to any lymphocyte proliferation. No evidence could be found for a possible adjuvant activity for RNA-DDA in cellular responses; in fact, RNA-DDA had an inhibitory effect on lymphocyte proliferative responses to Listeria antigen and to concanavalin A.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091505      PMCID: PMC260835          DOI: 10.1128/iai.53.3.611-615.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Activated macrophages in congenitally athymic "nude mice" and in lethally irradiate mice.

Authors:  C Cheers; R Waller
Journal:  J Immunol       Date:  1975-09       Impact factor: 5.422

2.  Macrophage activation in mice lacking thymus-derived (T) cells.

Authors:  R M Zinkernagel; R V Blanden
Journal:  Experientia       Date:  1975-05-15

3.  On the mechanism of T cell-independent anti-Listeria resistance in nude mice.

Authors:  M F Newborg; R J North
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

4.  Protection against Toxoplasma gondii in mice immunized with Toxoplasma cell fractions, RNA and synthetic polyribonucleotides.

Authors:  F G Araujo; J S Remington
Journal:  Immunology       Date:  1974-10       Impact factor: 7.397

5.  Protective ability of Salmonella ribosomal protein and RNA in inbred mice.

Authors:  M L Misfeldt; W Johnson
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

6.  Cell-mediated resistance to infection with Listeria monocytogenes in nude mice.

Authors:  P Emmerling; H Finger; H Hof
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

7.  Ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa.

Authors:  R Gonggrijp; W J Mullers; P J Lemmens; C P van Boven
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

8.  IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS.

Authors:  A S YOUMANS; G P YOUMANS
Journal:  J Bacteriol       Date:  1965-05       Impact factor: 3.490

9.  Anomalous high native resistance to athymic mice to bacterial pathogens.

Authors:  A D Nickol; P F Bonventre
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

10.  Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice.

Authors:  C Cheers; I F McKenzie; H Pavlov; C Waid; J York
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

View more
  1 in total

1.  Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model.

Authors:  C H Mody; G B Toews; M F Lipscomb
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.